help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0183
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/8/3071    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carvajal-Carmona, L. G.
Right arrow Articles by Tomlinson, I. P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carvajal-Carmona, L. G.
Right arrow Articles by Tomlinson, I. P. M.
Related Collections
Right arrow Endocrine Oncology
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 8 3071-3075
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Adult Leydig Cell Tumors of the Testis Caused by Germline Fumarate Hydratase Mutations

Luis G. Carvajal-Carmona, N. Afrina Alam, Patrick J. Pollard, Angela M. Jones, Ella Barclay, Noel Wortham, Massimo Pignatelli, Alex Freeman, Sabine Pomplun, Ian Ellis, Richard Poulsom, Mona A. El-Bahrawy, Daniel M. Berney and Ian P. M. Tomlinson

Molecular and Population Genetics Laboratory (L.G.C.-C., N.A.A., P.J.P., A.M.J., E.B., N.W., I.P.M.T.) and Histopathology Unit and In Situ Hybridisation Service (R.P.), London Research Institute, Cancer Research UK, London WC2A 3PX, United Kingdom; Department of Pathology and Microbiology, Division of Histopathology, Bristol Royal Infirmary (M.P.), Bristol BS2 8HW, United Kingdom; Department of Pathology, University College Hospital (A.F.), London WC1E 6JJ, United Kingdom; Department of Pathology, Kings College Hospital (S.P.), London SE5 9RS, United Kingdom; Department of Histopathology, Nottingham City Hospital (I.E.), Nottingham NG5 1PB, United Kingdom; Department of Histopathology, Division of Investigative Science, Imperial College (M.A.E.-B.), London WI2 0NN, United Kingdom; and Department of Pathology, St. Bartholomew’s Hospital (D.M.B.), London EC1A 7BE, United Kingdom

Address all correspondence and requests for reprints to: Dr. Luis G. Carvajal-Carmona, Ph.D., Laboratory of Molecular and Population Genetics, London Research Institute, Cancer Research UK, London WC2A 3PX, United Kingdom. E-mail: luis.carvajal{at}cancer.org.uk.

Context: Leydig cell tumors (LCTs) are the most common non-germ-cell neoplasms of the testis. LCTs are often hormonally active and can result in precocious virilization or in adult feminization. We identified an LCT in an affected individual from a kindred with hereditary leiomyomatosis and renal cell cancer (HLRCC) and a germline fumarate hydratase (FH) mutation (N64T).

Objective: Our objective was to investigate the role of FH mutations in predisposition to LCTs.

Design: We tested for pathogenic effects of the N64T mutation and screened an additional 29 unselected adult LCTs for FH alterations. We also tested these LCTs for mutations in two genes, the LH/choriogonadotropin receptor (LHCGR) and the guanine nucleotide-binding protein {alpha} (GNAS) that had been implicated in LCT tumorigenesis.

Results: No mutations were found in GNAS, and one tumor had a LHCGR somatic substitution. In addition to the HLRCC case with the N64T germline FH mutation, we identified one other LCT with a previously unreported FH mutation (M411I). Both LCTs from these patients showed loss of the wild-type FH allele. Immunohistochemical and in situ hybridization analyses demonstrated activation of the hypoxia/angiogenesis pathway not only in the tumors belonging to the FH mutation carriers but also in several other mutation-negative LCTs.

Conclusions: Our study shows that some LCTs are caused by FH mutations and represents one of the first reports of germline mutations in any type of adult testicular tumor.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. A. Mayr, D. Meierhofer, F. Zimmermann, R. Feichtinger, C. Kogler, M. Ratschek, N. Schmeller, W. Sperl, and B. Kofler
Loss of Complex I due to Mitochondrial DNA Mutations in Renal Oncocytoma
Clin. Cancer Res., April 15, 2008; 14(8): 2270 - 2275.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society